SBIR/STTR Research Award

High Resolution Fluorescent Melting Curve Analysis

Award identifier 76ee13307482b5f6d0db4f2ccea1bf2f8aeafab8c5bf66673e7541c60172eae6Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$0

Program and phase

STTR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
IDAHO TECHNOLOGY
Proposal award date
Not reported
Contract end date
Not reported
UEI
NHMDGM122546
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Applicant's abstract): Our long-term goal is to advance instrumentation and techniques for rapid, automated and sensitive variant analysis of nucleic acids. The LightCyclerTM has been our homogenous "closed system" platform for genotyping. Fluorescent hybridization probes are included at the beginning of the reaction and are used for realtime PCR monitoring and genotyping. After rapid cycle PCR, the reaction is slowly heated (0.1 degree C/s) and products are identified by unique probe/target melting temperatures. The entire assay is performed from genomic DNA within 20 min and without any sample manipulation. Fluorescent melting curve analysis is a useful and popular method for repetitive genotyping of established mutations/polymorphisms. In phase I, we built and tested a new "high-resolution" instrument for melting curve analysis. The high-resolution melting instrument has 10-fold less measurement error than the LightCyclerTM providing increased sensitivity for mutation detection and utility in mutation scanning. In phase II, we plan to integrate the "low noise" components of the high-resolution instrument into a modified LightCyclerTM to allow both rapid amplification and smooth melting curve genotyping. Mathematical software algorithms will be written for sensitive variant detection and flagging unknown mutant sequences. The utility of the new instrument and algorithms will be demonstrated by homogenously scanning for mutations within critical exons of the p53 gene. PROPOSED COMMERCIAL APPLICATION: We propose developing instrumentation and analysis software that will allow homogenous mutation scanning for the first time. The system will be used for scanning the p53 tumor suppressor gene, which is mutated in almost all cancers at the time of invasive growth. The instrumentation and the assay will be commercially available for continued research on p53 and to provide a clinical test for the prognosis and treatment of cancer. The general method can be applied to other genes, as well.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

26 SBIR/STTR records share this UEI (1999–2013). Reported award amounts total $6,448,942. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.